Co-Authors
This is a "connection" page, showing publications co-authored by Steven Riley and Christl Donnelly.
Connection Strength
2.492
-
Resurgence of SARS-CoV-2: Detection by community viral surveillance. Science. 2021 05 28; 372(6545):990-995.
Score: 0.235
-
Reduction in mobility and COVID-19 transmission. Nat Commun. 2021 02 17; 12(1):1090.
Score: 0.232
-
Response to COVID-19 in South Korea and implications for lifting stringent interventions. BMC Med. 2020 10 09; 18(1):321.
Score: 0.227
-
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment. Wellcome Open Res. 2020; 5:81.
Score: 0.226
-
REal-time Assessment of Community Transmission (REACT) of SARS-CoV-2 virus: Study protocol. Wellcome Open Res. 2020; 5:200.
Score: 0.225
-
Anonymised and aggregated crowd level mobility data from mobile phones suggests that initial compliance with COVID-19 social distancing interventions was high and geographically consistent across the UK. Wellcome Open Res. 2020; 5:170.
Score: 0.223
-
Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016. Philos Trans R Soc Lond B Biol Sci. 2017 May 26; 372(1721).
Score: 0.179
-
Epidemiological and genetic analysis of severe acute respiratory syndrome. Lancet Infect Dis. 2004 Nov; 4(11):672-83.
Score: 0.075
-
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet. 2003 May 24; 361(9371):1761-6.
Score: 0.068
-
Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science. 2003 Jun 20; 300(5627):1961-6.
Score: 0.068
-
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults. Lancet Reg Health Eur. 2021 May; 4:100098.
Score: 0.059
-
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic. Nat Commun. 2021 02 10; 12(1):905.
Score: 0.058
-
SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China. J Travel Med. 2020 12 23; 27(8).
Score: 0.058
-
State-level tracking of COVID-19 in the United States. Nat Commun. 2020 12 03; 11(1):6189.
Score: 0.057
-
Host or pathogen-related factors in COVID-19 severity? - Authors' reply. Lancet. 2020 10 31; 396(10260):1397.
Score: 0.057
-
Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China. Int J Infect Dis. 2021 Jan; 102:463-471.
Score: 0.057
-
Have deaths from COVID-19 in Europe plateaued due to herd immunity? Lancet. 2020 06 20; 395(10241):e110-e111.
Score: 0.055
-
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020 08; 584(7820):257-261.
Score: 0.055
-
Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. 2020 06; 20(6):669-677.
Score: 0.055
-
Key data for outbreak evaluation: building on the Ebola experience. Philos Trans R Soc Lond B Biol Sci. 2017 May 26; 372(1721).
Score: 0.045
-
Unraveling the drivers of MERS-CoV transmission. Proc Natl Acad Sci U S A. 2016 08 09; 113(32):9081-6.
Score: 0.042
-
Ebola Virus Disease among Male and Female Persons in West Africa. N Engl J Med. 2016 01 07; 374(1):96-8.
Score: 0.041
-
Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014 Jan; 14(1):50-56.
Score: 0.035
-
Seroprevalence of IgG antibodies to SARS-coronavirus in asymptomatic or subclinical population groups. Epidemiol Infect. 2006 Apr; 134(2):211-21.
Score: 0.021
-
SARS-CoV antibody prevalence in all Hong Kong patient contacts. Emerg Infect Dis. 2004 Sep; 10(9):1653-6.
Score: 0.019
-
Epidemiology, transmission dynamics and control of SARS: the 2002-2003 epidemic. Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29; 359(1447):1091-105.
Score: 0.018